"Rocky Mountain Cancer Centers (RMCC) is Colorado's largest and most comprehensive provider of cancer care with over 50 physicians, in nearly 20 community-based locations across the state. Our history is rich in forward thinking and best practice development. We were formed in 1992 when a group of independent medical oncology practices joined together to become a network of community-based clinic sites. This practice model has stood the test of time and continues to have proven clinical and economic benefit for patients, employers and payers today."

During the past decade, Rocky Mountain Cancer Centers-Sky Ridge conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 70 clinical trials were completed, i.e. on average, 63.1% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 46 clinical trials were completed. i.e. 148.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Sky Ridge" #1 sponsor was "National Cancer Institute (NCI)" with 73 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored and "Pfizer" with 14 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Sky Ridge" #1 collaborator was "National Cancer Institute (NCI)" with 84 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "ARMO BioSciences" with 2 trials as a collaborator and "Astellas Pharma Inc" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Cancer Centers-Sky Ridge" are "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Breast Cancer" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Rocky Mountain Cancer Centers-Sky Ridge" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Cancer Centers-Sky Ridge" are "Drug" (146 trials), "Other" (110 trials), "Biological" (80 trials), "Procedure" (44 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Quality-of-Life Assessment" (45 trials), "Questionnaire Administration" (25 trials), "Biospecimen Collection" (24 trials) and "Computed Tomography" (24 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Cancer Centers-Sky Ridge" are 149 trials for "All" genders, 35 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Rocky Mountain Cancer Centers-Sky Ridge". undefined are not yet recruiting, 46 are recruiting, 86 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Rocky Mountain Cancer Centers-Sky Ridge, 5 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Cancer Centers-Sky Ridge, 5 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".